Middlemore Clinical Trials
Private Bag 93311 New Zealand,
+64 9 270 9758  http://www.middlemoretrials.nz
Current and Upcoming Research Studies
To check your eligibility, please enter some information about yourself or call us on 0800 27 27 84. Any information you enter will be confidential and protected under the Privacy Act and the Health Information Privacy Code. This is simply a quick check to see if a study may be suitable for you. If it appears you are eligible for a study, one of our recruiters will be in touch with you shortly to provide you with more details.

Study NameEligibilitySend Info
Ankylosing Spondylitis/Axial SpondyloarthritisAge 18 years or older, have diagnosed Axial Spondyloarthritis
AURORA (3152-301-002)Aged between 18 to 75 years, diagnosed with 'Fatty liver', do not have Hepatitis B or C
Chronic Hepatitis BAge 18 – 65 years and have Chronic Hepatitis B infection
CKD / Type 2 DiabetesAre you aged ≥18 ≤79? Have been receiving stable treatment for your diabetes and diabetic kidney disease for the past 3 months? Are you able to participate in a study for up to 26 weeks?
Crohn's DiseaseHave Crohn's Disease, moderate to severe abdominal pain and/or daily unformed stool frequency >4, previous failure or intolerance to biologics (infliximab or humira), no ileostomy/colostomy
DeLIVERAre you aged between 22 and 70? Have you been diagnosed with Type 2 Diabetes? Are you on a consistent drug regimen of Metformin or Metformin/Vildagliptin only? Do you have a waist circumference ≥102 cm (male) and ≥88 cm (female)? Have you been diagnosed with hypertension:SBP ≥140 mmHg OR on ≤2 hypertension medications with SBP ≥130 mmHg?
Heart-FID (1VIT15043)Aged over 18 years, have Heart failure and mobile
IMG-7289-CTP-201Age over 18 Diagnosis of Essential Thrombocythemia Failure of standard therapy, e.g. Hydroxyurea
KER-050 Anemia in MDSAge over 18 Diagnosed with Myelodysplastic syndrome Anemia
KIWIAge over 18 Newly diagnosed symptomatic multiple myeloma
LYR-210Aged over 18, have chronic sinusitis, trialled at least two trials of medical treatments in the past (one of which must be intranasal corticosteroid sprays for at least 4 weeks) and no previous sinuplasty or endo-nasal surgery other than septoplasty or surgical manipulation to nasal turbinates
Momentum (SRA-MMB-301)Age over 18, Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis, Previously treated with Ruxolitinib
RSV TrialBaby born after October 2019, at 35 weeks gestation or above
Select - GCA (M16-852)Age 50 years or older, have diagnosed Giant Cell Arthritis, headache/jaw pain/vision loss, shoulder and/or hip pain
Systemic Lupus ErythematosusAge 18 years or older, have diagnosed Systemic Lupus Erythematosus
Type 2 DiabetesAged between 18 and 80 years of age, Type 2 Diabetes for at least 12 months, taking Metformin with no change in Diabetes treatment within the last 3 months
Type 2 Diabetes/Chronic Kidney DiseaseAge between 18-75 Diabetic Kidney Disease Type 2 Diabetes
Ulcerative colitisAge less than 65 years, have diagnosed ulcerative colitis and experiencing increase in daily stool frequency and/or rectal bleeding, no allergy to antibiotic vancomycin, willing to undergo two colonoscopy procedures as part of the study (3 months apart)
Click [Send Info] to receive more information about the research studies selected above:

www.bio-optronics.com
Visit our website to learn how Clinical Conductor is helping this site to manage its trials.